Niki Margari

Niki Margari

Auto-generated profile, based on publicly available information

Niki Margari

Independent Researcher, Greece

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2017 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
GMGeorgios‐Marios Makris
Georgios‐Marios Makris
APAbraham Pouliakis
Abraham Pouliakis
CSCharalampos Siristatidis
Charalampos Siristatidis
NMNiki Margari
Niki Margari
ETEmmanouil Terzakis
Emmanouil Terzakis
PKPetros Karakitsos
Petros Karakitsos

1 April 2016 in Gynecologic Oncology
Verified
Journal Article
Open access
Maria KyrgiouMaria Kyrgiou
Maria Kyrgiou
APAbraham Pouliakis
Abraham Pouliakis
JPJohn G. Panayiotides
John G. Panayiotides
NMNiki Margari
Niki Margari
PBPanagiotis Bountris
Panagiotis Bountris
EPEvangelos Paraskevaidis
Evangelos Paraskevaidis
To develop a clinical decision support scoring system (DSSS) based on artificial neural networks (ANN) for personalised management of women with cervical abnormalities. We recruited women with cervical abnormalities and healthy controls that attended for opportunistic screening between 2006 and 2014 in 3 University Hospitals. We prospectively collected detailed patient characteristics, the colposcopic impression and performed a series of biomarkers using a liquid-based cytology sample. These included HPV DNA typing, E6&E7 mRNA by NASBA or flow cytometry and p16INK4a immunostaining. We used ANNs to combine the cytology and biomarker results and develop a clinical DSSS with the aim to improve the diagnostic accuracy of tests and quantify the individual's risk for different histological diagnoses. We used histology as the gold standard. We analysed data from 2267 women that had complete or partial dataset of clinical and molecular data during their initial or followup visits (N=3565). Accuracy parameters (sensitivity, specificity, positive and negative predictive values) were assessed for the cytological result and/or HPV status and for the DSSS. The ANN predicted with higher accuracy the chances of high-grade (CIN2+), low grade (HPV/CIN1) and normal histology than cytology with or without HPV test. The sensitivity for prediction of CIN2 or worse was 93.0%, specificity 99.2% with high positive (93.3%) and negative (99.2%) predictive values. The DSSS based on an ANN of multilayer perceptron (MLP) type, can predict with the highest accuracy the histological diagnosis in women with abnormalities at cytology when compared with the use of tests alone. A user-friendly software based on this technology could be used to guide clinician decision making towards a more personalised care.

22 November 2013 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
APAbraham Pouliakis
Abraham Pouliakis
CMCharalampia Margari
Charalampia Margari
NMNiki Margari
Niki Margari
CCCharalampos Chrelias
Charalampos Chrelias
DZDimitrios Zygouris
Dimitrios Zygouris
PKPetros Karakitsos
Petros Karakitsos

1 December 2009 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
NSNikolaos Stergiou
Nikolaos Stergiou
GGGiannis Georgoulakis
Giannis Georgoulakis
NMNiki Margari
Niki Margari
DADionisios Aninos
Dionisios Aninos
MSMelina Stamataki
Melina Stamataki
PKPetros Karakitsos
Petros Karakitsos

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
PBPanagiotis Bountris
Panagiotis Bountris
MHMaria Haritou
Maria Haritou
APAbraham Pouliakis
Abraham Pouliakis
NMNiki Margari
Niki Margari
MKMaria Kyrgiou
Maria Kyrgiou
DKDimitrios-Dionyssios Koutsouris
Dimitrios-Dionyssios Koutsouris
Nowadays, there are molecular biology techniques providing information related to cervical cancer and its cause: the human Papillomavirus (HPV), including DNA microarrays identifying HPV subtypes, mRNA techniques such as nucleic acid based amplification or flow cytometry identifying E6/E7 oncogenes, and immunocytochemistry techniques such as overexpression of p16. Each one of these techniques has its own performance, limitations and advantages, thus a combinatorial approach via computational intelligence methods could exploit the benefits of each method and produce more accurate results. In this article we propose a clinical decision support system (CDSS), composed by artificial neural networks, intelligently combining the results of classic and ancillary techniques for diagnostic accuracy improvement. We evaluated this method on 740 cases with complete series of cytological assessment, molecular tests, and colposcopy examination. The CDSS demonstrated high sensitivity (89.4%), high specificity (97.1%), high positive predictive value (89.4%), and high negative predictive value (97.1%), for detecting cervical intraepithelial neoplasia grade 2 or worse (CIN2+). In comparison to the tests involved in this study and their combinations, the CDSS produced the most balanced results in terms of sensitivity, specificity, PPV, and NPV. The proposed system may reduce the referral rate for colposcopy and guide personalised management and therapeutic interventions.

1 September 2012 in Telemedicine and e-Health
Verified
Journal Article
Closed access
TTThomas Tsilalis
Thomas Tsilalis
SAStavros Archondakis
Stavros Archondakis
CMChristos Meristoudis
Christos Meristoudis
NMNiki Margari
Niki Margari
APAbraham Pouliakis
Abraham Pouliakis
PKPetros Karakitsos
Petros Karakitsos
Objective: This study evaluated the accuracy and reproducibility of telecytological diagnoses proffered on the basis of digitized images from cervical smears prepared by means of liquid-based cytology. Materials and Methods: Representative digital cytological images from a total of 404 cervical smears (benign, 135; atypical squamous cells of undetermined significance, 92; low-grade squamous intraepithelial lesion, 62; high-grade squamous intraepithelial lesion, 87; squamous cell carcinoma, 26; and adenocarcinoma, 2) were uploaded to the CytoTrainer e-learning telecytology platform (developed in the Department of Cytopathology, “ATTIKON” University General Hospital, Athens, Greece) with specific password-protected accounts and were reviewed remotely by four independent board-certified cytopathologists (checking round). Their reports were recorded and classified. After 12 and 24 months, the same representative digital images were transferred in random order to the same cytopathologists and were reviewed again (first and second review rounds, respectively). The cytopathologists' first and second round diagnoses were recorded and compared with their initial ones. Results: Statistical evaluation of cytological diagnoses detected no significant difference in diagnostic accuracy among checking and review diagnoses. The overall interobserver agreement was almost perfect with κ values of 0.79–0.97, whereas intraobserver agreement ranged from almost perfect to perfect with κ values of 0.76–1 in all diagnostic rounds. Conclusions: Digital images of cervical smears can be used for rapid and accurate diagnosis, by diminishing turnaround times and improving small cytology departments' quality indices. Diagnoses made by using static telecytological systems can be as reliable as those made by using conventional microscopy, under the conditions that representative images are taken and that standard cytological diagnostic criteria are applied. Telecytology can be used as an alternative method for the cytologic diagnosis of cervical smears, particularly in quality assurance programs.